

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | alpha-linolenic acid metabolic process (GO:0036109) | 5.47526514 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.00756182 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 5.00756182 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.99438221 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 4.99438221 |
| 6 | valine metabolic process (GO:0006573) | 4.94264466 |
| 7 | regulation of sequestering of triglyceride (GO:0010889) | 4.83798754 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.81866699 |
| 9 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.73449315 |
| 10 | regulation of triglyceride catabolic process (GO:0010896) | 4.65419483 |
| 11 | sulfur amino acid catabolic process (GO:0000098) | 4.63739924 |
| 12 | fatty acid beta-oxidation (GO:0006635) | 4.41823633 |
| 13 | positive regulation of fatty acid oxidation (GO:0046321) | 4.38959577 |
| 14 | biotin metabolic process (GO:0006768) | 4.37610519 |
| 15 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.30305060 |
| 16 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.23568941 |
| 17 | triglyceride catabolic process (GO:0019433) | 4.21211182 |
| 18 | low-density lipoprotein particle clearance (GO:0034383) | 4.19385645 |
| 19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.18545809 |
| 20 | fatty acid oxidation (GO:0019395) | 4.18307868 |
| 21 | lysine metabolic process (GO:0006553) | 4.17331911 |
| 22 | lysine catabolic process (GO:0006554) | 4.17331911 |
| 23 | plasma lipoprotein particle assembly (GO:0034377) | 4.14398430 |
| 24 | acylglycerol catabolic process (GO:0046464) | 4.13953167 |
| 25 | neutral lipid catabolic process (GO:0046461) | 4.13953167 |
| 26 | fatty acid transmembrane transport (GO:1902001) | 4.13879557 |
| 27 | lipid oxidation (GO:0034440) | 4.10206666 |
| 28 | aromatic amino acid family catabolic process (GO:0009074) | 4.09482254 |
| 29 | fatty acid catabolic process (GO:0009062) | 4.06674077 |
| 30 | complement activation, alternative pathway (GO:0006957) | 4.06319096 |
| 31 | cysteine metabolic process (GO:0006534) | 4.05451768 |
| 32 | triglyceride homeostasis (GO:0070328) | 4.04734367 |
| 33 | acylglycerol homeostasis (GO:0055090) | 4.04734367 |
| 34 | regulation of fatty acid oxidation (GO:0046320) | 3.98230077 |
| 35 | positive regulation of lipid catabolic process (GO:0050996) | 3.98194810 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 3.94551728 |
| 37 | protein-lipid complex assembly (GO:0065005) | 3.91605619 |
| 38 | regulation of plasminogen activation (GO:0010755) | 3.91154958 |
| 39 | 2-oxoglutarate metabolic process (GO:0006103) | 3.87085722 |
| 40 | plasma lipoprotein particle clearance (GO:0034381) | 3.86343915 |
| 41 | acetyl-CoA metabolic process (GO:0006084) | 3.84493040 |
| 42 | carnitine shuttle (GO:0006853) | 3.84266715 |
| 43 | bile acid biosynthetic process (GO:0006699) | 3.82559583 |
| 44 | high-density lipoprotein particle remodeling (GO:0034375) | 3.82309353 |
| 45 | short-chain fatty acid metabolic process (GO:0046459) | 3.82195874 |
| 46 | amino-acid betaine metabolic process (GO:0006577) | 3.81633267 |
| 47 | branched-chain amino acid catabolic process (GO:0009083) | 3.80341752 |
| 48 | protein carboxylation (GO:0018214) | 3.73969166 |
| 49 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.73969166 |
| 50 | monocarboxylic acid catabolic process (GO:0072329) | 3.73150548 |
| 51 | blood coagulation, intrinsic pathway (GO:0007597) | 3.72587450 |
| 52 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.72272916 |
| 53 | urea cycle (GO:0000050) | 3.70808934 |
| 54 | urea metabolic process (GO:0019627) | 3.70808934 |
| 55 | regulation of apoptotic cell clearance (GO:2000425) | 3.69688679 |
| 56 | branched-chain amino acid metabolic process (GO:0009081) | 3.69428279 |
| 57 | reverse cholesterol transport (GO:0043691) | 3.69388634 |
| 58 | negative regulation of fibrinolysis (GO:0051918) | 3.69200081 |
| 59 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.68497378 |
| 60 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.68497378 |
| 61 | ethanol oxidation (GO:0006069) | 3.66977380 |
| 62 | regulation of protein activation cascade (GO:2000257) | 3.63520540 |
| 63 | ethanol metabolic process (GO:0006067) | 3.60953545 |
| 64 | glyoxylate metabolic process (GO:0046487) | 3.59190141 |
| 65 | regulation of extracellular matrix disassembly (GO:0010715) | 3.58447929 |
| 66 | serine family amino acid catabolic process (GO:0009071) | 3.58007956 |
| 67 | positive regulation of extracellular matrix organization (GO:1903055) | 3.56219029 |
| 68 | kynurenine metabolic process (GO:0070189) | 3.55860260 |
| 69 | fibrinolysis (GO:0042730) | 3.55751581 |
| 70 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.54539559 |
| 71 | diacylglycerol metabolic process (GO:0046339) | 3.54383479 |
| 72 | regulation of cholesterol homeostasis (GO:2000188) | 3.51361986 |
| 73 | homocysteine metabolic process (GO:0050667) | 3.47703193 |
| 74 | regulation of complement activation (GO:0030449) | 3.47501994 |
| 75 | intestinal cholesterol absorption (GO:0030299) | 3.46315812 |
| 76 | regulation of triglyceride metabolic process (GO:0090207) | 3.46091357 |
| 77 | negative regulation of lipase activity (GO:0060192) | 3.41250745 |
| 78 | complement activation, classical pathway (GO:0006958) | 3.41149885 |
| 79 | nitrogen cycle metabolic process (GO:0071941) | 3.40515647 |
| 80 | thioester biosynthetic process (GO:0035384) | 3.39679234 |
| 81 | acyl-CoA biosynthetic process (GO:0071616) | 3.39679234 |
| 82 | proline metabolic process (GO:0006560) | 3.39563094 |
| 83 | acute-phase response (GO:0006953) | 3.39213381 |
| 84 | bile acid metabolic process (GO:0008206) | 3.39209999 |
| 85 | protein activation cascade (GO:0072376) | 3.37837925 |
| 86 | tryptophan catabolic process (GO:0006569) | 3.36751069 |
| 87 | indole-containing compound catabolic process (GO:0042436) | 3.36751069 |
| 88 | indolalkylamine catabolic process (GO:0046218) | 3.36751069 |
| 89 | regulation of fibrinolysis (GO:0051917) | 3.35273430 |
| 90 | regulation of extracellular matrix organization (GO:1903053) | 3.34867848 |
| 91 | protein-lipid complex remodeling (GO:0034368) | 3.33586680 |
| 92 | macromolecular complex remodeling (GO:0034367) | 3.33586680 |
| 93 | plasma lipoprotein particle remodeling (GO:0034369) | 3.33586680 |
| 94 | cholesterol efflux (GO:0033344) | 3.33473149 |
| 95 | tricarboxylic acid metabolic process (GO:0072350) | 3.33185256 |
| 96 | plasma lipoprotein particle organization (GO:0071827) | 3.31704997 |
| 97 | alpha-amino acid catabolic process (GO:1901606) | 3.31591181 |
| 98 | low-density lipoprotein particle remodeling (GO:0034374) | 3.31222808 |
| 99 | carnitine metabolic process (GO:0009437) | 3.29942300 |
| 100 | organic acid catabolic process (GO:0016054) | 3.28736786 |
| 101 | carboxylic acid catabolic process (GO:0046395) | 3.28736786 |
| 102 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.27670535 |
| 103 | cellular amino acid catabolic process (GO:0009063) | 3.27342598 |
| 104 | positive regulation of blood coagulation (GO:0030194) | 3.25668063 |
| 105 | positive regulation of hemostasis (GO:1900048) | 3.25668063 |
| 106 | protein-lipid complex subunit organization (GO:0071825) | 3.24284278 |
| 107 | regulation of lipid catabolic process (GO:0050994) | 3.23806654 |
| 108 | triglyceride metabolic process (GO:0006641) | 3.23572256 |
| 109 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.20572516 |
| 110 | oxaloacetate metabolic process (GO:0006107) | 3.19095737 |
| 111 | complement activation (GO:0006956) | 3.18301813 |
| 112 | NADH metabolic process (GO:0006734) | 3.17652544 |
| 113 | tryptophan metabolic process (GO:0006568) | 3.17537509 |
| 114 | epoxygenase P450 pathway (GO:0019373) | 3.17448933 |
| 115 | cellular ketone body metabolic process (GO:0046950) | 3.16753908 |
| 116 | regulation of cholesterol storage (GO:0010885) | 3.16732066 |
| 117 | cellular modified amino acid catabolic process (GO:0042219) | 3.16504020 |
| 118 | negative regulation of cholesterol transport (GO:0032375) | 3.15409852 |
| 119 | negative regulation of sterol transport (GO:0032372) | 3.15409852 |
| 120 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.15108799 |
| 121 | phospholipid efflux (GO:0033700) | 3.13572868 |
| 122 | fatty acid homeostasis (GO:0055089) | 3.12129288 |
| 123 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.11356906 |
| 124 | acylglycerol metabolic process (GO:0006639) | 3.10512408 |
| 125 | regulation of humoral immune response (GO:0002920) | 3.09858821 |
| 126 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.09342658 |
| 127 | carnitine transmembrane transport (GO:1902603) | 3.09294563 |
| 128 | regulation of bile acid biosynthetic process (GO:0070857) | 3.08418231 |
| 129 | tyrosine metabolic process (GO:0006570) | 3.07914710 |
| 130 | negative regulation of blood coagulation (GO:0030195) | 3.07768744 |
| 131 | negative regulation of hemostasis (GO:1900047) | 3.07768744 |
| 132 | coenzyme catabolic process (GO:0009109) | 3.07690682 |
| 133 | neutral lipid metabolic process (GO:0006638) | 3.06013290 |
| 134 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.02584029 |
| 135 | positive regulation of coagulation (GO:0050820) | 3.01149306 |
| 136 | negative regulation of protein activation cascade (GO:2000258) | 2.98834682 |
| 137 | regulation of cholesterol metabolic process (GO:0090181) | 2.91829323 |
| 138 | progesterone metabolic process (GO:0042448) | 2.90532767 |
| 139 | intestinal absorption (GO:0050892) | 2.87927396 |
| 140 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.84432020 |
| 141 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.79497813 |
| 142 | negative regulation of fatty acid transport (GO:2000192) | 2.78695267 |
| 143 | proline biosynthetic process (GO:0006561) | 2.78486613 |
| 144 | negative regulation of lipid transport (GO:0032369) | 2.76577957 |
| 145 | exogenous drug catabolic process (GO:0042738) | 2.74989135 |
| 146 | negative regulation of coagulation (GO:0050819) | 2.72841305 |
| 147 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.67444204 |
| 148 | negative regulation of wound healing (GO:0061045) | 2.67167049 |
| 149 | lipoprotein metabolic process (GO:0042157) | 2.67089166 |
| 150 | basement membrane organization (GO:0071711) | 2.66597818 |
| 151 | Golgi transport vesicle coating (GO:0048200) | 2.65044110 |
| 152 | COPI coating of Golgi vesicle (GO:0048205) | 2.65044110 |
| 153 | glutamate metabolic process (GO:0006536) | 2.64109768 |
| 154 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.61807257 |
| 155 | response to mercury ion (GO:0046689) | 2.59528120 |
| 156 | cellular glucuronidation (GO:0052695) | 2.54786827 |
| 157 | positive regulation of steroid metabolic process (GO:0045940) | 2.54691951 |
| 158 | acute inflammatory response (GO:0002526) | 2.54292834 |
| 159 | cholesterol homeostasis (GO:0042632) | 2.50249454 |
| 160 | negative regulation of complement activation (GO:0045916) | 2.50246983 |
| 161 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.49872537 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.07076054 |
| 2 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.00372720 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.05357929 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.28831072 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.72495060 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.88660927 |
| 7 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.88097890 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.37833141 |
| 9 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.28990616 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.16250975 |
| 11 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.08233945 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.37990390 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.14512964 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 2.08837129 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.06565501 |
| 16 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.95554178 |
| 17 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.88876304 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.87073063 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.80502641 |
| 20 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.72418547 |
| 21 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.58812315 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.52542292 |
| 23 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.51362890 |
| 24 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.48101721 |
| 25 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.46310758 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.43883968 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.43874842 |
| 28 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.41747248 |
| 29 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.41434105 |
| 30 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37489878 |
| 31 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.36215658 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.31452479 |
| 33 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.30783131 |
| 34 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.29708211 |
| 35 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28487784 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.28220906 |
| 37 | MAF_26560356_Chip-Seq_TH1_Human | 1.27160688 |
| 38 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.25578138 |
| 39 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.24505290 |
| 40 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.22490693 |
| 41 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21836646 |
| 42 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21545418 |
| 43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.20822919 |
| 44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.20162818 |
| 45 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.19844934 |
| 46 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.19231541 |
| 47 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17779738 |
| 48 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17719369 |
| 49 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.17193933 |
| 50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16026834 |
| 51 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.15750727 |
| 52 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.14997692 |
| 53 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.13610005 |
| 54 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.13607044 |
| 55 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.10491744 |
| 56 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.10371184 |
| 57 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.09063221 |
| 58 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07875305 |
| 59 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.07852239 |
| 60 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.07338711 |
| 61 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06647748 |
| 62 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.03650462 |
| 63 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.02449773 |
| 64 | MAF_26560356_Chip-Seq_TH2_Human | 1.01605234 |
| 65 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.00068279 |
| 66 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.00061763 |
| 67 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.99987933 |
| 68 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99392585 |
| 69 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.98772486 |
| 70 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.98290781 |
| 71 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.98229384 |
| 72 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.97710474 |
| 73 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97597330 |
| 74 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.95958462 |
| 75 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95749610 |
| 76 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.94602604 |
| 77 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94560534 |
| 78 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.94500536 |
| 79 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.94171231 |
| 80 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.94079031 |
| 81 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.94079031 |
| 82 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93573893 |
| 83 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.93368600 |
| 84 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.92916780 |
| 85 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92364081 |
| 86 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.89577794 |
| 87 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.89024995 |
| 88 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.88649291 |
| 89 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88624317 |
| 90 | KDM2B_26808549_Chip-Seq_K562_Human | 0.88062340 |
| 91 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.87920568 |
| 92 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87055469 |
| 93 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.86984152 |
| 94 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.86525510 |
| 95 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.85903471 |
| 96 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.84244629 |
| 97 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84010576 |
| 98 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.83998863 |
| 99 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83600308 |
| 100 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.82417866 |
| 101 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.81358413 |
| 102 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.79984817 |
| 103 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.79879598 |
| 104 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.79131630 |
| 105 | * P68_20966046_ChIP-Seq_HELA_Human | 0.77556357 |
| 106 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.76945796 |
| 107 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.76918099 |
| 108 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74658487 |
| 109 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.74422003 |
| 110 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.74086066 |
| 111 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.73703142 |
| 112 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.72564499 |
| 113 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.72441327 |
| 114 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.72126229 |
| 115 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.72090710 |
| 116 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.71935140 |
| 117 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.71832417 |
| 118 | GATA2_19941826_ChIP-Seq_K562_Human | 0.71749038 |
| 119 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.71243254 |
| 120 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.71110170 |
| 121 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.70909815 |
| 122 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.70890028 |
| 123 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.70241563 |
| 124 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.70230099 |
| 125 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.68447354 |
| 126 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68118664 |
| 127 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.68108801 |
| 128 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.68083542 |
| 129 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.68063145 |
| 130 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.67496774 |
| 131 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.67043436 |
| 132 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.65267086 |
| 133 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.63657185 |
| 134 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.63267280 |
| 135 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.62277889 |
| 136 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.62250733 |
| 137 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.61088677 |
| 138 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.61046336 |
| 139 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.60809197 |
| 140 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.59855020 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.87924118 |
| 2 | MP0005365_abnormal_bile_salt | 4.98081436 |
| 3 | MP0005360_urolithiasis | 4.83302185 |
| 4 | MP0005670_abnormal_white_adipose | 4.07211021 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 4.06617967 |
| 6 | MP0010329_abnormal_lipoprotein_level | 3.66021153 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.25288109 |
| 8 | MP0004130_abnormal_muscle_cell | 3.04425713 |
| 9 | MP0003252_abnormal_bile_duct | 2.84738532 |
| 10 | MP0005666_abnormal_adipose_tissue | 2.79864310 |
| 11 | MP0005451_abnormal_body_composition | 2.67445345 |
| 12 | MP0009840_abnormal_foam_cell | 2.45713174 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.45470528 |
| 14 | MP0002118_abnormal_lipid_homeostasis | 2.40946890 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.32249306 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 2.30421648 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.28946448 |
| 18 | MP0005332_abnormal_amino_acid | 2.27304336 |
| 19 | MP0004185_abnormal_adipocyte_glucose | 2.16410531 |
| 20 | MP0005375_adipose_tissue_phenotype | 2.12359460 |
| 21 | MP0000609_abnormal_liver_physiology | 2.09690261 |
| 22 | MP0002971_abnormal_brown_adipose | 2.08951518 |
| 23 | MP0003195_calcinosis | 2.01944300 |
| 24 | MP0008438_abnormal_cutaneous_collagen | 2.01215242 |
| 25 | MP0005083_abnormal_biliary_tract | 1.98711385 |
| 26 | MP0000013_abnormal_adipose_tissue | 1.92914345 |
| 27 | MP0002837_dystrophic_cardiac_calcinosis | 1.91181213 |
| 28 | MP0003566_abnormal_cell_adhesion | 1.88505690 |
| 29 | MP0003436_decreased_susceptibility_to | 1.76859829 |
| 30 | MP0001984_abnormal_olfaction | 1.74493434 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 1.71365504 |
| 32 | MP0000858_altered_metastatic_potential | 1.70879138 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.69825224 |
| 34 | MP0003011_delayed_dark_adaptation | 1.67757423 |
| 35 | MP0000003_abnormal_adipose_tissue | 1.67685770 |
| 36 | MP0002132_abnormal_respiratory_system | 1.65690758 |
| 37 | MP0002909_abnormal_adrenal_gland | 1.57090628 |
| 38 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55908331 |
| 39 | MP0005334_abnormal_fat_pad | 1.54887259 |
| 40 | MP0005275_abnormal_skin_tensile | 1.53945910 |
| 41 | MP0005409_darkened_coat_color | 1.53402372 |
| 42 | MP0008260_abnormal_autophagy | 1.52195078 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.50309517 |
| 44 | MP0001661_extended_life_span | 1.48062658 |
| 45 | MP0002078_abnormal_glucose_homeostasis | 1.47242254 |
| 46 | MP0005535_abnormal_body_temperature | 1.47234424 |
| 47 | MP0003172_abnormal_lysosome_physiology | 1.47033256 |
| 48 | MP0004019_abnormal_vitamin_homeostasis | 1.47007456 |
| 49 | MP0004264_abnormal_extraembryonic_tissu | 1.45990635 |
| 50 | MP0005257_abnormal_intraocular_pressure | 1.41951305 |
| 51 | MP0002089_abnormal_postnatal_growth/wei | 1.36300700 |
| 52 | MP0003868_abnormal_feces_composition | 1.35550134 |
| 53 | MP0003303_peritoneal_inflammation | 1.35203623 |
| 54 | MP0006036_abnormal_mitochondrial_physio | 1.33180094 |
| 55 | MP0009643_abnormal_urine_homeostasis | 1.33042394 |
| 56 | MP0005076_abnormal_cell_differentiation | 1.31909287 |
| 57 | MP0002166_altered_tumor_susceptibility | 1.30760703 |
| 58 | MP0000685_abnormal_immune_system | 1.30599414 |
| 59 | MP0001764_abnormal_homeostasis | 1.30074978 |
| 60 | MP0003091_abnormal_cell_migration | 1.26616829 |
| 61 | MP0005448_abnormal_energy_balance | 1.25654361 |
| 62 | MP0003183_abnormal_peptide_metabolism | 1.25438691 |
| 63 | MP0009115_abnormal_fat_cell | 1.25295724 |
| 64 | MP0002970_abnormal_white_adipose | 1.23867465 |
| 65 | MP0008961_abnormal_basal_metabolism | 1.23500136 |
| 66 | MP0001849_ear_inflammation | 1.21781193 |
| 67 | MP0010234_abnormal_vibrissa_follicle | 1.15333591 |
| 68 | MP0003959_abnormal_lean_body | 1.13784102 |
| 69 | MP0001348_abnormal_lacrimal_gland | 1.13653052 |
| 70 | MP0003656_abnormal_erythrocyte_physiolo | 1.12730992 |
| 71 | MP0003453_abnormal_keratinocyte_physiol | 1.12396258 |
| 72 | MP0005023_abnormal_wound_healing | 1.11311645 |
| 73 | MP0004858_abnormal_nervous_system | 1.11205687 |
| 74 | MP0002933_joint_inflammation | 1.11100727 |
| 75 | MP0001915_intracranial_hemorrhage | 1.10708856 |
| 76 | MP0004947_skin_inflammation | 1.09378024 |
| 77 | MP0009333_abnormal_splenocyte_physiolog | 1.08803387 |
| 78 | MP0003724_increased_susceptibility_to | 1.08378513 |
| 79 | MP0002876_abnormal_thyroid_physiology | 1.07235322 |
| 80 | MP0005220_abnormal_exocrine_pancreas | 1.06690348 |
| 81 | MP0003186_abnormal_redox_activity | 1.06106356 |
| 82 | MP0001958_emphysema | 1.05875868 |
| 83 | MP0002090_abnormal_vision | 1.01210307 |
| 84 | MP0005647_abnormal_sex_gland | 1.00172036 |
| 85 | MP0010155_abnormal_intestine_physiology | 1.00000901 |
| 86 | MP0000678_abnormal_parathyroid_gland | 0.95886162 |
| 87 | MP0003763_abnormal_thymus_physiology | 0.95096644 |
| 88 | MP0009780_abnormal_chondrocyte_physiolo | 0.94867916 |
| 89 | MP0001756_abnormal_urination | 0.94493620 |
| 90 | MP0001533_abnormal_skeleton_physiology | 0.93652394 |
| 91 | MP0000598_abnormal_liver_morphology | 0.93312415 |
| 92 | MP0000566_synostosis | 0.89705243 |
| 93 | MP0001851_eye_inflammation | 0.88916786 |
| 94 | MP0003329_amyloid_beta_deposits | 0.88202704 |
| 95 | MP0000604_amyloidosis | 0.87616978 |
| 96 | MP0005025_abnormal_response_to | 0.87499442 |
| 97 | MP0004043_abnormal_pH_regulation | 0.87174167 |
| 98 | MP0001881_abnormal_mammary_gland | 0.86532875 |
| 99 | MP0003953_abnormal_hormone_level | 0.85287785 |
| 100 | MP0000249_abnormal_blood_vessel | 0.84726654 |
| 101 | MP0001944_abnormal_pancreas_morphology | 0.84382978 |
| 102 | MP0010368_abnormal_lymphatic_system | 0.82458854 |
| 103 | MP0005387_immune_system_phenotype | 0.81302028 |
| 104 | MP0001790_abnormal_immune_system | 0.81302028 |
| 105 | MP0005408_hypopigmentation | 0.81292728 |
| 106 | MP0009642_abnormal_blood_homeostasis | 0.78536427 |
| 107 | MP0008469_abnormal_protein_level | 0.77034378 |
| 108 | MP0000767_abnormal_smooth_muscle | 0.76640937 |
| 109 | MP0004782_abnormal_surfactant_physiolog | 0.76233051 |
| 110 | MP0005636_abnormal_mineral_homeostasis | 0.76187744 |
| 111 | MP0005330_cardiomyopathy | 0.74011156 |
| 112 | MP0002254_reproductive_system_inflammat | 0.73288132 |
| 113 | MP0002998_abnormal_bone_remodeling | 0.72951166 |
| 114 | MP0002060_abnormal_skin_morphology | 0.72892173 |
| 115 | MP0000230_abnormal_systemic_arterial | 0.72800222 |
| 116 | MP0005164_abnormal_response_to | 0.72798408 |
| 117 | MP0003879_abnormal_hair_cell | 0.71447598 |
| 118 | MP0005452_abnormal_adipose_tissue | 0.71289543 |
| 119 | MP0002796_impaired_skin_barrier | 0.70874047 |
| 120 | MP0003300_gastrointestinal_ulcer | 0.70566556 |
| 121 | MP0002249_abnormal_larynx_morphology | 0.70147519 |
| 122 | MP0001800_abnormal_humoral_immune | 0.68829326 |
| 123 | MP0002419_abnormal_innate_immunity | 0.68577523 |
| 124 | MP0005058_abnormal_lysosome_morphology | 0.66759160 |
| 125 | MP0008775_abnormal_heart_ventricle | 0.66460269 |
| 126 | MP0009763_increased_sensitivity_to | 0.66428166 |
| 127 | MP0003690_abnormal_glial_cell | 0.65362169 |
| 128 | MP0005551_abnormal_eye_electrophysiolog | 0.65289430 |
| 129 | MP0006138_congestive_heart_failure | 0.64658258 |
| 130 | MP0009384_cardiac_valve_regurgitation | 0.63173258 |
| 131 | MP0005084_abnormal_gallbladder_morpholo | 0.62650281 |
| 132 | MP0004147_increased_porphyrin_level | 0.61298738 |
| 133 | MP0002269_muscular_atrophy | 0.60629731 |
| 134 | MP0004272_abnormal_basement_membrane | 0.60262744 |
| 135 | MP0004087_abnormal_muscle_fiber | 0.58516042 |
| 136 | MP0006035_abnormal_mitochondrial_morpho | 0.58371942 |
| 137 | MP0005248_abnormal_Harderian_gland | 0.57183806 |
| 138 | MP0004036_abnormal_muscle_relaxation | 0.56195573 |
| 139 | MP0003221_abnormal_cardiomyocyte_apopto | 0.54798349 |
| 140 | MP0005376_homeostasis/metabolism_phenot | 0.54335997 |
| 141 | MP0004084_abnormal_cardiac_muscle | 0.52876079 |
| 142 | MP0009765_abnormal_xenobiotic_induced | 0.51556025 |
| 143 | MP0002877_abnormal_melanocyte_morpholog | 0.50036445 |
| 144 | MP0009764_decreased_sensitivity_to | 0.49899012 |
| 145 | MP0005620_abnormal_muscle_contractility | 0.49662890 |
| 146 | MP0000751_myopathy | 0.49228108 |
| 147 | MP0002168_other_aberrant_phenotype | 0.48874433 |
| 148 | MP0005595_abnormal_vascular_smooth | 0.48819485 |
| 149 | MP0005266_abnormal_metabolism | 0.48096975 |
| 150 | MP0000639_abnormal_adrenal_gland | 0.47900093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.07419233 |
| 2 | Hyperglycinuria (HP:0003108) | 5.03722702 |
| 3 | Deep venous thrombosis (HP:0002625) | 4.95081832 |
| 4 | Xanthomatosis (HP:0000991) | 4.93133886 |
| 5 | Hypoglycemic coma (HP:0001325) | 4.69147877 |
| 6 | Ketosis (HP:0001946) | 4.46381503 |
| 7 | Abnormality of glycine metabolism (HP:0010895) | 4.44693022 |
| 8 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.44693022 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.40416579 |
| 10 | Hyperglycinemia (HP:0002154) | 4.34716122 |
| 11 | Complement deficiency (HP:0004431) | 4.21553425 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 4.19601887 |
| 13 | Hyperammonemia (HP:0001987) | 4.08851802 |
| 14 | Ketoacidosis (HP:0001993) | 4.00760501 |
| 15 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.99939236 |
| 16 | Systemic lupus erythematosus (HP:0002725) | 3.90487476 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 3.87628980 |
| 18 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.83468095 |
| 19 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.79020896 |
| 20 | Epidermoid cyst (HP:0200040) | 3.70079295 |
| 21 | Hypobetalipoproteinemia (HP:0003563) | 3.66418194 |
| 22 | Hypolipoproteinemia (HP:0010981) | 3.57443792 |
| 23 | Prolonged partial thromboplastin time (HP:0003645) | 3.53228811 |
| 24 | Glomerulonephritis (HP:0000099) | 3.46256067 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.39034122 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.23684826 |
| 27 | Myoglobinuria (HP:0002913) | 3.23130521 |
| 28 | Oligomenorrhea (HP:0000876) | 3.20006309 |
| 29 | Abnormality of the common coagulation pathway (HP:0010990) | 3.11169230 |
| 30 | Menorrhagia (HP:0000132) | 3.04249731 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.04230577 |
| 32 | Dicarboxylic aciduria (HP:0003215) | 3.01591883 |
| 33 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.01591883 |
| 34 | Abnormality of complement system (HP:0005339) | 2.90565281 |
| 35 | Abnormality of proline metabolism (HP:0010907) | 2.84565690 |
| 36 | Hydroxyprolinuria (HP:0003080) | 2.84565690 |
| 37 | Flat acetabular roof (HP:0003180) | 2.83287166 |
| 38 | Purpura (HP:0000979) | 2.82349105 |
| 39 | Hypercholesterolemia (HP:0003124) | 2.82239712 |
| 40 | Hypertriglyceridemia (HP:0002155) | 2.80688608 |
| 41 | Skin nodule (HP:0200036) | 2.79785731 |
| 42 | Nephritis (HP:0000123) | 2.70220000 |
| 43 | Hypoglycemic seizures (HP:0002173) | 2.69277438 |
| 44 | Gingival bleeding (HP:0000225) | 2.64895729 |
| 45 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.59560628 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.58735885 |
| 47 | Acanthosis nigricans (HP:0000956) | 2.58081500 |
| 48 | Abnormality of serum amino acid levels (HP:0003112) | 2.55513592 |
| 49 | Fat malabsorption (HP:0002630) | 2.53377187 |
| 50 | Generalized aminoaciduria (HP:0002909) | 2.51986917 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.48636606 |
| 52 | Hyperbilirubinemia (HP:0002904) | 2.45572426 |
| 53 | Eczematoid dermatitis (HP:0000976) | 2.44096365 |
| 54 | Metabolic acidosis (HP:0001942) | 2.43511426 |
| 55 | Late onset (HP:0003584) | 2.41633280 |
| 56 | Myocardial infarction (HP:0001658) | 2.38931643 |
| 57 | Hyperglycemia (HP:0003074) | 2.37323241 |
| 58 | Abnormality of carpal bone ossification (HP:0006257) | 2.35095998 |
| 59 | Mitral stenosis (HP:0001718) | 2.33789280 |
| 60 | Brushfield spots (HP:0001088) | 2.33614461 |
| 61 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.33272401 |
| 62 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.32645148 |
| 63 | Abnormal tarsal ossification (HP:0008369) | 2.29853871 |
| 64 | Rhabdomyolysis (HP:0003201) | 2.29029102 |
| 65 | Pigmentary retinal degeneration (HP:0001146) | 2.27157382 |
| 66 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.25205086 |
| 67 | Vertebral compression fractures (HP:0002953) | 2.25189527 |
| 68 | Joint hemorrhage (HP:0005261) | 2.24590019 |
| 69 | Pancreatitis (HP:0001733) | 2.22757710 |
| 70 | Cholelithiasis (HP:0001081) | 2.22119881 |
| 71 | Insulin resistance (HP:0000855) | 2.21423277 |
| 72 | Abnormal cartilage morphology (HP:0002763) | 2.21228433 |
| 73 | Lethargy (HP:0001254) | 2.19418084 |
| 74 | Abnormal gallbladder morphology (HP:0012437) | 2.18948498 |
| 75 | Cerebral aneurysm (HP:0004944) | 2.15652000 |
| 76 | Gout (HP:0001997) | 2.14960866 |
| 77 | Vascular calcification (HP:0004934) | 2.14268531 |
| 78 | Hepatocellular carcinoma (HP:0001402) | 2.11945558 |
| 79 | Cholecystitis (HP:0001082) | 2.10969019 |
| 80 | Abnormal gallbladder physiology (HP:0012438) | 2.10969019 |
| 81 | Conjugated hyperbilirubinemia (HP:0002908) | 2.07939887 |
| 82 | Abnormal ossification of hand bones (HP:0005921) | 2.07374013 |
| 83 | Gastrointestinal infarctions (HP:0005244) | 2.05279047 |
| 84 | Arterial tortuosity (HP:0005116) | 2.03385853 |
| 85 | Cardiovascular calcification (HP:0011915) | 2.03323605 |
| 86 | Sensorimotor neuropathy (HP:0007141) | 2.03262058 |
| 87 | Abnormal platelet volume (HP:0011876) | 2.03133736 |
| 88 | Hemorrhage of the eye (HP:0011885) | 2.02442839 |
| 89 | Delayed CNS myelination (HP:0002188) | 2.02146373 |
| 90 | Prolonged bleeding time (HP:0003010) | 1.99578955 |
| 91 | Epistaxis (HP:0000421) | 1.99012091 |
| 92 | Abnormality of nucleobase metabolism (HP:0010932) | 1.98666615 |
| 93 | Back pain (HP:0003418) | 1.98465745 |
| 94 | Rickets (HP:0002748) | 1.97575132 |
| 95 | Polygenic inheritance (HP:0010982) | 1.96638449 |
| 96 | Vascular tortuosity (HP:0004948) | 1.96261844 |
| 97 | Increased mean platelet volume (HP:0011877) | 1.95966560 |
| 98 | Cupped ribs (HP:0000887) | 1.95406818 |
| 99 | Palpitations (HP:0001962) | 1.95072789 |
| 100 | Vomiting (HP:0002013) | 1.93805285 |
| 101 | Neonatal onset (HP:0003623) | 1.93199956 |
| 102 | Aneurysm (HP:0002617) | 1.91211428 |
| 103 | Small epiphyses (HP:0010585) | 1.91110369 |
| 104 | Growth hormone excess (HP:0000845) | 1.90590620 |
| 105 | Asymmetry of the thorax (HP:0001555) | 1.89488214 |
| 106 | Irritability (HP:0000737) | 1.89386979 |
| 107 | Nausea (HP:0002018) | 1.89227138 |
| 108 | Peritonitis (HP:0002586) | 1.87662553 |
| 109 | Abnormality of methionine metabolism (HP:0010901) | 1.87636889 |
| 110 | Subcapsular cataract (HP:0000523) | 1.87025479 |
| 111 | Coxa vara (HP:0002812) | 1.86995664 |
| 112 | Poikilocytosis (HP:0004447) | 1.86062679 |
| 113 | Malnutrition (HP:0004395) | 1.85039764 |
| 114 | Limb hypertonia (HP:0002509) | 1.84815972 |
| 115 | Cerebral edema (HP:0002181) | 1.84527345 |
| 116 | Polycythemia (HP:0001901) | 1.84508997 |
| 117 | Increased muscle lipid content (HP:0009058) | 1.84408965 |
| 118 | Amyloidosis (HP:0011034) | 1.83801466 |
| 119 | Thin bony cortex (HP:0002753) | 1.83446279 |
| 120 | Premature rupture of membranes (HP:0001788) | 1.83103352 |
| 121 | Emphysema (HP:0002097) | 1.81363177 |
| 122 | Protrusio acetabuli (HP:0003179) | 1.81254614 |
| 123 | Acanthocytosis (HP:0001927) | 1.80615553 |
| 124 | Turricephaly (HP:0000262) | 1.79986631 |
| 125 | Right ventricular cardiomyopathy (HP:0011663) | 1.78856388 |
| 126 | Central scotoma (HP:0000603) | 1.77939953 |
| 127 | Achilles tendon contracture (HP:0001771) | 1.77722640 |
| 128 | Colitis (HP:0002583) | 1.77680206 |
| 129 | Steatorrhea (HP:0002570) | 1.77446871 |
| 130 | Tetraparesis (HP:0002273) | 1.77315317 |
| 131 | Abnormality of the gallbladder (HP:0005264) | 1.75905484 |
| 132 | Exercise-induced myalgia (HP:0003738) | 1.75145027 |
| 133 | Spastic diplegia (HP:0001264) | 1.73693391 |
| 134 | Spontaneous abortion (HP:0005268) | 1.72850890 |
| 135 | Long toe (HP:0010511) | 1.72648595 |
| 136 | Abnormal hand bone ossification (HP:0010660) | 1.71798429 |
| 137 | Abnormality of the Achilles tendon (HP:0005109) | 1.71644046 |
| 138 | Stroke (HP:0001297) | 1.71166182 |
| 139 | Cellulitis (HP:0100658) | 1.71055302 |
| 140 | Gastrointestinal stroma tumor (HP:0100723) | 1.70940506 |
| 141 | Abnormal foot bone ossification (HP:0010675) | 1.70611912 |
| 142 | Gingivitis (HP:0000230) | 1.70217956 |
| 143 | Hypophosphatemia (HP:0002148) | 1.68140908 |
| 144 | Thrombophlebitis (HP:0004418) | 1.67312643 |
| 145 | Blue sclerae (HP:0000592) | 1.66644649 |
| 146 | Metaphyseal cupping (HP:0003021) | 1.66214712 |
| 147 | Pulmonary embolism (HP:0002204) | 1.65320436 |
| 148 | Elevated alkaline phosphatase (HP:0003155) | 1.64955647 |
| 149 | Biconcave vertebral bodies (HP:0004586) | 1.64099938 |
| 150 | Hypochromic anemia (HP:0001931) | 1.63914398 |
| 151 | Dilatation of the ascending aorta (HP:0005111) | 1.60568832 |
| 152 | Mucopolysacchariduria (HP:0008155) | 1.60537515 |
| 153 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.60537515 |
| 154 | Osteomalacia (HP:0002749) | 1.60424710 |
| 155 | Aortic aneurysm (HP:0004942) | 1.59927710 |
| 156 | Cerebral inclusion bodies (HP:0100314) | 1.58324286 |
| 157 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.55719826 |
| 158 | Abnormality of the peritoneum (HP:0002585) | 1.55228241 |
| 159 | Abnormality of the acetabulum (HP:0003170) | 1.55123005 |
| 160 | Increased IgE level (HP:0003212) | 1.54854883 |
| 161 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.54600616 |
| 162 | Osteoarthritis (HP:0002758) | 1.54531620 |
| 163 | Increased variability in muscle fiber diameter (HP:0003557) | 1.54031750 |
| 164 | Bronchomalacia (HP:0002780) | 1.53570895 |
| 165 | Abnormality of the lumbar spine (HP:0100712) | 1.52617280 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.41682018 |
| 2 | TRIB3 | 5.34157771 |
| 3 | ERN1 | 4.08373245 |
| 4 | SIK1 | 4.02377937 |
| 5 | PRPF4B | 3.18166470 |
| 6 | CAMK1D | 2.80973207 |
| 7 | CDK12 | 2.73893144 |
| 8 | PKN2 | 2.73687879 |
| 9 | SMG1 | 2.34474418 |
| 10 | RIPK1 | 2.33485826 |
| 11 | INSRR | 2.14316951 |
| 12 | FGFR4 | 2.06677553 |
| 13 | PDK4 | 2.05991321 |
| 14 | PDK3 | 2.05991321 |
| 15 | CAMK1G | 1.99703988 |
| 16 | LATS1 | 1.84147896 |
| 17 | RIPK4 | 1.57907676 |
| 18 | MAP3K13 | 1.55624722 |
| 19 | TAOK3 | 1.50981924 |
| 20 | LMTK2 | 1.50941714 |
| 21 | PDGFRA | 1.50269235 |
| 22 | ICK | 1.47116181 |
| 23 | MAP4K1 | 1.46861801 |
| 24 | EPHA2 | 1.46374272 |
| 25 | PTK6 | 1.44666643 |
| 26 | FRK | 1.43079070 |
| 27 | EEF2K | 1.42231221 |
| 28 | MATK | 1.36383011 |
| 29 | PHKG1 | 1.28276276 |
| 30 | PHKG2 | 1.28276276 |
| 31 | PINK1 | 1.24091404 |
| 32 | FLT3 | 1.22863092 |
| 33 | TESK1 | 1.17455624 |
| 34 | DAPK2 | 1.16954043 |
| 35 | MST1R | 1.16281390 |
| 36 | PRKAA2 | 1.14594197 |
| 37 | CDC42BPA | 1.12181675 |
| 38 | MAPKAPK3 | 1.11442567 |
| 39 | PIK3CG | 1.10408159 |
| 40 | PRKD3 | 1.10214086 |
| 41 | ZAP70 | 1.08510583 |
| 42 | PDK2 | 1.07449729 |
| 43 | EPHA3 | 1.07282132 |
| 44 | GRK6 | 1.00943410 |
| 45 | MAP3K7 | 0.97279170 |
| 46 | ARAF | 0.96945345 |
| 47 | PRKAA1 | 0.95977872 |
| 48 | MAP2K1 | 0.93846605 |
| 49 | DDR2 | 0.93816232 |
| 50 | DYRK1B | 0.92998486 |
| 51 | MAPK11 | 0.92760956 |
| 52 | RET | 0.91275888 |
| 53 | SIK2 | 0.89771870 |
| 54 | KSR2 | 0.86323570 |
| 55 | LATS2 | 0.84430348 |
| 56 | TAOK2 | 0.84073896 |
| 57 | PAK3 | 0.83291119 |
| 58 | MAP3K11 | 0.82479753 |
| 59 | MAP2K4 | 0.81960394 |
| 60 | FER | 0.81372851 |
| 61 | MAP3K10 | 0.80828810 |
| 62 | MTOR | 0.80434208 |
| 63 | JAK2 | 0.78631416 |
| 64 | MAP3K2 | 0.75291619 |
| 65 | EPHB2 | 0.74364081 |
| 66 | TGFBR2 | 0.73890991 |
| 67 | IRAK3 | 0.71445964 |
| 68 | CSK | 0.70967865 |
| 69 | JAK1 | 0.70332992 |
| 70 | PDPK1 | 0.66695388 |
| 71 | MAP3K6 | 0.65806518 |
| 72 | MAP3K14 | 0.65683394 |
| 73 | TTN | 0.64898072 |
| 74 | MAPK15 | 0.63878741 |
| 75 | PTK2 | 0.63482700 |
| 76 | TAOK1 | 0.63073626 |
| 77 | JAK3 | 0.63071943 |
| 78 | CDK9 | 0.62567282 |
| 79 | CDK6 | 0.61101495 |
| 80 | PRKD2 | 0.60525840 |
| 81 | CAMKK1 | 0.60177983 |
| 82 | BMX | 0.59620572 |
| 83 | MAP2K2 | 0.59478636 |
| 84 | PRKACG | 0.59227326 |
| 85 | CDK4 | 0.58727359 |
| 86 | CDK7 | 0.57879713 |
| 87 | HIPK2 | 0.57761119 |
| 88 | FGFR2 | 0.57120300 |
| 89 | TIE1 | 0.56934631 |
| 90 | NEK1 | 0.56262880 |
| 91 | STK38 | 0.55371122 |
| 92 | PRKCH | 0.55204657 |
| 93 | NTRK1 | 0.54742704 |
| 94 | MAP3K1 | 0.54202604 |
| 95 | SIK3 | 0.53696261 |
| 96 | PRKCZ | 0.52336661 |
| 97 | PRKD1 | 0.51966282 |
| 98 | STK38L | 0.51855108 |
| 99 | PRKG2 | 0.51831274 |
| 100 | IRAK1 | 0.51383602 |
| 101 | PAK2 | 0.51299762 |
| 102 | FGFR3 | 0.51219931 |
| 103 | MAP3K9 | 0.51110650 |
| 104 | IRAK4 | 0.50458896 |
| 105 | PAK6 | 0.47336366 |
| 106 | CSF1R | 0.46922228 |
| 107 | BTK | 0.45788945 |
| 108 | MAPK12 | 0.45292328 |
| 109 | MAP3K3 | 0.45036047 |
| 110 | PDK1 | 0.44801511 |
| 111 | MET | 0.44358929 |
| 112 | HCK | 0.44141474 |
| 113 | PAK4 | 0.43977705 |
| 114 | RPS6KC1 | 0.43828814 |
| 115 | RPS6KL1 | 0.43828814 |
| 116 | CAMKK2 | 0.43566875 |
| 117 | BLK | 0.43228943 |
| 118 | NEK9 | 0.41226990 |
| 119 | TNK2 | 0.40908724 |
| 120 | MAP3K8 | 0.40024366 |
| 121 | WNK1 | 0.39941736 |
| 122 | IKBKE | 0.38893376 |
| 123 | YES1 | 0.38889258 |
| 124 | LRRK2 | 0.38340978 |
| 125 | ERBB2 | 0.37769152 |
| 126 | IRAK2 | 0.37613591 |
| 127 | FGR | 0.37227833 |
| 128 | TYK2 | 0.37167455 |
| 129 | BRAF | 0.36479336 |
| 130 | MYLK | 0.36337626 |
| 131 | NLK | 0.35839323 |
| 132 | GSK3A | 0.35789372 |
| 133 | CAMK2G | 0.35744125 |
| 134 | TYRO3 | 0.35464714 |
| 135 | SGK3 | 0.35322987 |
| 136 | AKT3 | 0.34912659 |
| 137 | MAP2K3 | 0.34500585 |
| 138 | MARK2 | 0.32800178 |
| 139 | PDGFRB | 0.31557169 |
| 140 | EPHB1 | 0.31132276 |
| 141 | RPS6KA2 | 0.30942261 |
| 142 | ILK | 0.30564266 |
| 143 | DAPK3 | 0.29150044 |
| 144 | CSNK1G1 | 0.29018891 |
| 145 | TBK1 | 0.28758592 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.22293606 |
| 2 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.18739790 |
| 3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.10222556 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.09368219 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.94883180 |
| 6 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.83711499 |
| 7 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.70629805 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62492673 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.40004558 |
| 10 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.37415762 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.31411447 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.28884573 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.22124344 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.18902946 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.17726709 |
| 16 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.04497627 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.02041242 |
| 18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.94684408 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.83672355 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.83085843 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.82923003 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.79980035 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73007195 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.69611062 |
| 25 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.66721062 |
| 26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.64706393 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.49028560 |
| 28 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.41497568 |
| 29 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.40033803 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.37807335 |
| 31 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31271402 |
| 32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.30522210 |
| 33 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.29354084 |
| 34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.27118376 |
| 35 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.26853831 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.23312194 |
| 37 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21485161 |
| 38 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.20453347 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.19793183 |
| 40 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.17946395 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.17880322 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.16675083 |
| 43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.15609745 |
| 44 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.14442588 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.14358245 |
| 46 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.12630159 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.10670859 |
| 48 | Retinol metabolism_Homo sapiens_hsa00830 | 1.09447052 |
| 49 | Histidine metabolism_Homo sapiens_hsa00340 | 1.08607705 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.04089757 |
| 51 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.03964799 |
| 52 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.03684931 |
| 53 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.00153532 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.99761824 |
| 55 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.99110927 |
| 56 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.99086424 |
| 57 | Endometrial cancer_Homo sapiens_hsa05213 | 0.96878728 |
| 58 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.96166401 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95864915 |
| 60 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.95060732 |
| 61 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.91822977 |
| 62 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.86869497 |
| 63 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.86515343 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 0.86198429 |
| 65 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.85491241 |
| 66 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.82752190 |
| 67 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.79957766 |
| 68 | Thyroid cancer_Homo sapiens_hsa05216 | 0.79072855 |
| 69 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.78811988 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 0.76798909 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.72615146 |
| 72 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72020510 |
| 73 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.71594328 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.69397138 |
| 75 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68814899 |
| 76 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68301057 |
| 77 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66590402 |
| 78 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.65558326 |
| 79 | Bladder cancer_Homo sapiens_hsa05219 | 0.64018492 |
| 80 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.63777896 |
| 81 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63417933 |
| 82 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.62068205 |
| 83 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61696206 |
| 84 | Focal adhesion_Homo sapiens_hsa04510 | 0.60267604 |
| 85 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58476973 |
| 86 | Prostate cancer_Homo sapiens_hsa05215 | 0.57237303 |
| 87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56831797 |
| 88 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56123168 |
| 89 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.54262875 |
| 90 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.53074693 |
| 91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52897988 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50904414 |
| 93 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50768058 |
| 94 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.50244665 |
| 95 | Pertussis_Homo sapiens_hsa05133 | 0.50200271 |
| 96 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.48846142 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | 0.48712081 |
| 98 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.48077760 |
| 99 | Adherens junction_Homo sapiens_hsa04520 | 0.47797744 |
| 100 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47557606 |
| 101 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.47091953 |
| 102 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47020383 |
| 103 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46591228 |
| 104 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.46158894 |
| 105 | Leishmaniasis_Homo sapiens_hsa05140 | 0.45867990 |
| 106 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.44607804 |
| 107 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44402783 |
| 108 | Influenza A_Homo sapiens_hsa05164 | 0.44009810 |
| 109 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.43701780 |
| 110 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.42340529 |
| 111 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41765783 |
| 112 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41080542 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40986071 |
| 114 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.39894471 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39194896 |
| 116 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36921170 |
| 117 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36730439 |
| 118 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.36499350 |
| 119 | Olfactory transduction_Homo sapiens_hsa04740 | 0.34041521 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.33747553 |
| 121 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.32563563 |
| 122 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.28068638 |
| 123 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26635173 |
| 124 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.25052286 |
| 125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.23829993 |
| 126 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.22160004 |
| 127 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.21581020 |
| 128 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.20739319 |
| 129 | Circadian rhythm_Homo sapiens_hsa04710 | 0.15771911 |
| 130 | Insulin secretion_Homo sapiens_hsa04911 | 0.15583410 |
| 131 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.15358159 |
| 132 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.15182180 |
| 133 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.15129307 |
| 134 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.14864417 |
| 135 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.14585524 |
| 136 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.12368152 |
| 137 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.10843446 |
| 138 | Renin secretion_Homo sapiens_hsa04924 | 0.08876710 |
| 139 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.08601960 |
| 140 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.06081098 |
| 141 | Lysosome_Homo sapiens_hsa04142 | 0.05957424 |

